Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT in Treatment Resistant Depression
NCT04805879Phase 3Unknown
- Sponsor
- University of Calgary
- Start
- Mar 2021
- Primary completion
- Mar 2024
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 3 trial of Fecal Microbiota Transplantation Capsule in major depressive disorder (MDD), sponsored by University of Calgary. Status: unknown.
02
Drugs
Fecal Microbiota Transplantation Capsule
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT04805879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04805879.